CV Sciences (CVSI) Long-Term Deferred Tax (2022 - 2025)
CV Sciences (CVSI) posted Long-Term Deferred Tax of $13.5 million for Q4 2025, down 1.28% sequentially from $13.7 million in Q4 2024, and down 1.28% YoY from $13.7 million in Q4 2024.
CV Sciences (CVSI) Long-Term Deferred Tax (2022 - 2025) Analysis & Trends
CV Sciences has reported Long-Term Deferred Tax for 4 years, with the latest figure at $13.5 million in Q4 2025.
- Quarterly Long-Term Deferred Tax fell 1.28% year-over-year to $13.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $13.5 million (down 1.28% YoY) and the FY2025 annual result came in at $13.5 million, down 1.28% from the prior year.
- Long-Term Deferred Tax eased to $13.5 million in Q4 2025 per CVSI's latest filing, from $13.7 million in the prior quarter.
- Over five years, Long-Term Deferred Tax peaked at $17.9 million in Q4 2022 and troughed at $13.5 million in Q4 2025.
- A 4-year average of $15.6 million and a median of $15.4 million in 2023 frame the typical range for Long-Term Deferred Tax.
- The sharpest annual moves came in 2024 and 2025: Long-Term Deferred Tax declined 20.28% in 2024, then dropped 1.28% in 2025.
- Over 4 years, Long-Term Deferred Tax stood at $17.9 million in 2022, then declined by 4.28% to $17.1 million in 2023, then slipped by 20.28% to $13.7 million in 2024, then retreated by 1.28% to $13.5 million in 2025.
- According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $13.5 million, $13.7 million, and $17.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.49 Mn |
| Dec 31, 2024 | 13.67 Mn |
| Dec 31, 2023 | 17.15 Mn |
| Dec 31, 2022 | 17.91 Mn |